Whittier Trust’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-750
| Closed | -$8.74K | – | 1551 |
|
|
2024
Q4 | $8.74K | Sell |
750
-10
| -1% | -$117 | ﹤0.01% | 1268 |
|
|
2024
Q3 | $15.6K | Hold |
760
| – | – | ﹤0.01% | 1172 |
|
|
2024
Q2 | $17K | Hold |
760
| – | – | ﹤0.01% | 1129 |
|
|
2024
Q1 | $20.9K | Hold |
760
| – | – | ﹤0.01% | 1114 |
|
|
2023
Q4 | $23.2K | Sell |
760
-452
| -37% | -$13.8K | ﹤0.01% | 1075 |
|
|
2023
Q3 | $38.3K | Buy |
1,212
+4
| +0.3% | +$126 | ﹤0.01% | 975 |
|
|
2023
Q2 | $49.2K | Hold |
1,208
| – | – | ﹤0.01% | 934 |
|
|
2023
Q1 | $45K | Hold |
1,208
| – | – | ﹤0.01% | 985 |
|
|
2022
Q4 | $42.1K | Buy |
1,208
+448
| +59% | +$15.6K | ﹤0.01% | 996 |
|
|
2022
Q3 | $43K | Hold |
760
| – | – | ﹤0.01% | 994 |
|
|
2022
Q2 | $39K | Hold |
760
| – | – | ﹤0.01% | 1010 |
|
|
2022
Q1 | $55K | Hold |
760
| – | – | ﹤0.01% | 950 |
|
|
2021
Q4 | $90K | Buy |
760
+367
| +93% | +$43.5K | ﹤0.01% | 850 |
|
|
2021
Q3 | $53K | Hold |
393
| – | – | ﹤0.01% | 918 |
|
|
2021
Q2 | $64K | Hold |
393
| – | – | ﹤0.01% | 897 |
|
|
2021
Q1 | $32K | Hold |
393
| – | – | ﹤0.01% | 1037 |
|
|
2020
Q4 | $21K | Hold |
393
| – | – | ﹤0.01% | 1035 |
|
|
2020
Q3 | $8K | Hold |
393
| – | – | ﹤0.01% | 1163 |
|
|
2020
Q2 | $8K | Hold |
393
| – | – | ﹤0.01% | 1098 |
|
|
2020
Q1 | $5K | Hold |
393
| – | – | ﹤0.01% | 1218 |
|
|
2019
Q4 | $6K | Hold |
393
| – | – | ﹤0.01% | 1218 |
|
|
2019
Q3 | $5K | Hold |
393
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q2 | $6K | Hold |
393
| – | – | ﹤0.01% | 1133 |
|
|
2019
Q1 | $7K | Hold |
393
| – | – | ﹤0.01% | 1106 |
|
|
2018
Q4 | $5K | Hold |
393
| – | – | ﹤0.01% | 1166 |
|
|
2018
Q3 | $11K | Hold |
393
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q2 | $11K | Buy |
+393
| New | +$11K | ﹤0.01% | 1018 |
|